Public Employees Retirement System of Ohio Lowers Position in ICU Medical, Inc. $ICUI

Public Employees Retirement System of Ohio lessened its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 30.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 6,546 shares of the medical instruments supplier’s stock after selling 2,934 shares during the period. Public Employees Retirement System of Ohio’s holdings in ICU Medical were worth $845,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of ICUI. Hilton Head Capital Partners LLC bought a new position in shares of ICU Medical in the fourth quarter worth about $32,000. Covestor Ltd raised its stake in ICU Medical by 22.1% during the 4th quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock worth $99,000 after acquiring an additional 126 shares during the period. Strs Ohio raised its stake in ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after acquiring an additional 300 shares during the period. Rockefeller Capital Management L.P. lifted its holdings in ICU Medical by 21.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares in the last quarter. Finally, Kemnay Advisory Services Inc. purchased a new position in ICU Medical during the fourth quarter valued at approximately $120,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on ICUI shares. Weiss Ratings raised shares of ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 23rd. Needham & Company LLC upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 target price on the stock in a research note on Wednesday, May 27th. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. BTIG Research initiated coverage on ICU Medical in a research note on Monday, June 15th. They issued a “buy” rating and a $170.00 price target for the company. Finally, Piper Sandler decreased their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $172.00.

Insider Activity at ICU Medical

In related news, Director David C. Greenberg sold 2,424 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total value of $297,933.84. Following the completion of the sale, the director directly owned 7,960 shares in the company, valued at $978,363.60. This trade represents a 23.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $124.08, for a total transaction of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares of the company’s stock, valued at $2,414,596.80. The trade was a 11.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.10% of the stock is owned by company insiders.

ICU Medical Stock Up 2.6%

Shares of NASDAQ ICUI opened at $172.94 on Tuesday. The company has a current ratio of 2.34, a quick ratio of 1.17 and a debt-to-equity ratio of 0.60. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $176.27. The firm’s 50-day moving average price is $148.81 and its 200-day moving average price is $140.40. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of 93.48, a P/E/G ratio of 2.35 and a beta of 0.76.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The company had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. During the same quarter last year, the business posted $1.72 earnings per share. The firm’s revenue was down 12.3% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities research analysts anticipate that ICU Medical, Inc. will post 6.51 EPS for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.